Provided by Tiger Fintech (Singapore) Pte. Ltd.

Generation Bio Co.

0.3904
+0.03048.44%
Pre-market: 0.3705-0.0199-5.10%08:52 EDT
Volume:902.48K
Turnover:353.10K
Market Cap:26.17M
PE:-0.36
High:0.4184
Open:0.3800
Low:0.3701
Close:0.3600
Loading ...

Generation Bio Price Target Maintained With a $8.00/Share by Needham

Dow Jones
·
08 May

Generation Bio Q1 EPS $(0.22) Beats $(0.29) Estimate, Sales $8.72M Beat $2.13M Estimate

Benzinga
·
08 May

BRIEF-Generation Bio Q1 EPS USD -0.22

Reuters
·
08 May

Generation Bio Q1 EPS USD -0.22

THOMSON REUTERS
·
08 May

Generation Bio Q1 Net Income USD -14.802 Million

THOMSON REUTERS
·
08 May

Generation Bio Price Target Maintained With a $8.00/Share by Needham

Dow Jones
·
10 Apr

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

GlobeNewswire
·
02 Apr

Generation Bio Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
17 Mar

Generation Bio Co. (NASDAQ:GBIO) Not Doing Enough For Some Investors As Its Shares Slump 29%

Simply Wall St.
·
16 Mar

Generation Bio Co reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
14 Mar

Generation Bio Price Target Maintained With a $8.00/Share by Needham

Dow Jones
·
14 Mar

Hold Rating on Generation Bio Amid Strategic Focus and Financial Uncertainty

TIPRANKS
·
14 Mar

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sutro Biopharma (STRO) and Generation Bio (GBIO)

TIPRANKS
·
14 Mar

Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
14 Mar

Generation Bio Q4 2024 GAAP EPS $(0.32), Inline, Sales $4.188 Miss $2.500M Estimate

Benzinga
·
14 Mar

BRIEF-Generation Bio Q4 Basic EPS USD -0.32

Reuters
·
14 Mar

Generation Bio Q4 Basic EPS USD -0.32

THOMSON REUTERS
·
14 Mar

Generation Bio Co - Q4 Collaboration Revenue $4.19 Mln

THOMSON REUTERS
·
14 Mar

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
14 Mar

Generation Bio Co expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
28 Feb